17β-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner

Young Mi Seok, E. J. Jang, Oliver Reiser, Markus Hager, In Kyeom Kim

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

17β-Estradiol (E2) exerts rapid non-genomic vascular effects through activation of its plasma membrane receptors. We tested the hypothesis that E2 induces vasorelaxation through activation of the G-protein-coupled receptor 30 (GPR30) in rat aorta. Rat aortic rings were mounted in organ baths and subjected to contraction followed by relaxation. Whether endothelium was intact or denuded, both E2 and G1, a GPR30 agonist, induced vasorelaxation in concentration-dependent manners. Although G15, a specific GPR30 antagonist, blocked G1-induced vasorelaxation, it did not block E2-induced vasorelaxation. In conclusion, 17β-estradiol induces vasorelaxation in a GPR30-independent manner in rat aorta.

Original languageEnglish
Pages (from-to)945-948
Number of pages4
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume385
Issue number9
DOIs
StatePublished - Sep 2012

Keywords

  • 17β-Estradiol
  • G-protein-coupled receptor 30 (GPR30)
  • G1
  • G15
  • Vasorelaxation

Fingerprint

Dive into the research topics of '17β-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner'. Together they form a unique fingerprint.

Cite this